The following statement applies to all emails sent by CLINUVEL staff internally and externally:
This message and its attachments may contain confidential information. It is intended solely for the named addressee. If you are not the addressee indicated in this message, you may not copy or deliver this message or its attachments to anyone. It is requested that you permanently delete this message and its attachments and kindly notify the sender by reply email. Except where this email indicates otherwise, views expressed in this email are those of the sender and not of CLINUVEL PHARMACEUTICALS LTD. Employees of CLINUVEL PHARMACEUTICALS LTD are expressly required not to make defamatory statements and not to infringe or authorize any infringement of copyright or any other legal right by email communications. To the extent permissible by law, CLINUVEL PHARMACEUTICALS LTD shall not be liable for any errors, omissions, defects or misrepresentations of content in the email or for any loss or damage suffered by persons who use or rely on such content. If any law prohibits the exclusion of such liability, CLINUVEL PHARMACEUTICALS LTD limits its liability to the re-supply of the content, provided it is fair and reasonable and permissible by law. CLINUVEL PHARMACEUTICALS LTD does not accept any liability for any investment decisions made on the basis of the contents held in this email. Nothing in this email constitutes or is intended to constitute an offer of, or an invitation to purchase or subscribe for, securities in CLINUVEL PHARMACEUTICALS LTD. Although the company has taken reasonable precautions to ensure no viruses are present in this email, the company cannot accept responsibility for any loss or damage arising from the use of this email or attachments.